Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TissueFlow is a medical technology company specializing in the development of advanced systems for autologous tissue grafting. Its flagship product, the TissueFlow™ system, is a closed-loop, sterile, and disposable device designed for the efficient collection, processing, and transfer of adipose tissue. The technology streamlines the fat grafting process by providing a simplified workflow that maintains tissue viability and minimizes contamination risks. TissueFlow's solutions are primarily utilized in plastic, reconstructive, and aesthetic surgical procedures to improve patient outcomes in volume restoration and tissue repair. The company's platform is engineered to integrate seamlessly into existing surgical environments, offering a cost-effective and high-yield alternative to traditional tissue processing methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TissueFlow.